Skip to main content
Haleon PLC logo

Haleon PLC — Investor Relations & Filings

Ticker · HLN ISIN · GB00BMX86B70 LEI · 549300PSB3WWEODCUP19 IL Manufacturing
Open in API
Filings indexed 898 across all filing types
Latest filing 2026-01-06 Director's Dealing
Country GB United Kingdom
Listing IL HLN

About Haleon PLC

https://www.haleon.com/

Haleon PLC is a global consumer healthcare company focused on improving everyday health. The company develops and markets a portfolio of category-leading brands built on scientific innovation and trusted by consumers and healthcare professionals. Its product offerings span several key categories, including Oral Health, Pain Relief, Respiratory Health, and Vitamins, Minerals, and Supplements. Notable brands within its portfolio include Sensodyne, Advil, Voltaren, and Centrum. Haleon's mission is to deliver better everyday health with humanity, making it more achievable, inclusive, and sustainable.

Recent filings

Filing Released Lang Actions
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is a notification of transactions by Persons Discharging Managerial Responsibilities (PDMRs) at Haleon plc, detailing acquisitions of shares by specific executives. It includes names, positions, transaction details, dates, and places of transactions. The document is a regulatory announcement about insider share dealings, not a financial report, earnings release, or management discussion. It fits the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives. The document length (6207 characters) supports it being a full notification rather than a brief announcement. Therefore, the correct classification is DIRS with high confidence.
2026-01-06 English
TOTAL VOTING RIGHTS AND CAPITAL
Foreign Filer Report
2026-01-02 English
Total Voting Rights and Capital
Regulatory Filings Classification · 98% confidence The document is a standard regulatory announcement regarding 'Total Voting Rights and Capital'. It provides the total number of shares issued and the number of shares with voting rights as of a specific date (31 December 2025). This type of disclosure is a routine regulatory requirement for companies listed on the London Stock Exchange to assist shareholders in calculating their notification obligations under the FCA's Disclosure Guidance and Transparency Rules. Since it does not fit into specific categories like 'Share Issue' (which would imply a change or new issuance) or 'Major Shareholding Notification' (which is a report from a shareholder), it is best classified as a general regulatory filing (RNS).
2026-01-02 English
BOARD AND COMMITTEE CHANGES
Foreign Filer Report
2025-12-15 English
Board and Committee Changes
Board/Management Information Classification · 100% confidence The document is an official announcement from Haleon plc regarding changes to its Board of Directors and Committee structure, specifically the appointment of a new Senior Independent Director and changes to committee memberships. This falls directly under the definition of Board/Management Information (MANG).
2025-12-15 English
DIRECTOR/PDMR SHAREHOLDING
Foreign Filer Report
2025-12-10 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.